Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

MAIA Biotechnology Inc. (MAIA)

  • Company Report
  • March 18, 2024, 13:05 UTC
  • 177

Understanding Clinical Trials - Part 1 of 2

Comment Full text

MAIA Biotechnology Inc. (MAIA)

  • Company Report
  • July 18, 2023, 17:52 UTC
  • 125

Understanding Clinical Trials - Part 1 of 2

Comment Full text

MAIA Biotechnology Inc. (MAIA)

  • Company Report
  • April 23, 2023, 16:00 UTC
  • 106

Understanding Clinical Trials - Part 1 of 2

Comment Full text

Regeneron Pharmaceuticals Inc (REGN)

  • Company Report
  • April 21, 2023, 23:20 UTC
  • 107

New Form ARS for Regeneron Pharmaceuticals, Inc.

Comment Full text

Fate Therapeutics Inc (FATE)

  • Company Report
  • April 21, 2023, 23:14 UTC
  • 96

New Form ARS for Fate Therapeutics, Inc.

Comment Full text

GlycoMimetics Inc. (GLYC)

  • Company Report
  • April 21, 2023, 19:44 UTC
  • 101

New Form ARS for GlycoMimetics, Inc.

Comment Full text

MAIA Biotechnology Inc. (MAIA)

  • Company Report
  • April 21, 2023, 18:57 UTC
  • 99

Preliminary Survival for THIO-101 program

Comment Full text

Cabaletta Bio Inc (CABA)

  • Company Report
  • April 21, 2023, 14:10 UTC
  • 95

New SEC Form for Cabaletta Bio, Inc.

Comment Full text

Ligand Pharmaceuticals Incorporated (LGND)

  • Company Report
  • April 20, 2023, 23:15 UTC
  • 104

New SEC Form for Ligand Pharmaceuticals Incorporated

Comment Full text

VolitionRX Limited (VNRX)

  • Company Report
  • April 20, 2023, 17:35 UTC
  • 102

Webinar - Unravelling the web of NETs in sepsis

Comment Full text
  • 1
  • 2
  • 3
  • Next

Search

News categories

  • Technical Exchange News(9413)
  • Event(407)
  • SEC News(154317)
  • FDA Approval(8862)
  • Company Report(721)
  • Business News(105183)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin